Debt to EBITDA ratio Analysis of Heron Therapeuti - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of HRTX
Dec-23-1.51Very Poor Debt to EBITDA | Dec-22-0.857Very Poor Debt to EBITDA | Growth-76.82% |
Debt to EBITDA Analysis of Heron Therapeuti
| Debt to EBITDA Ratio of HRTX drastically fell by -76.82 % this year. |
| Debt to EBITDA Ratio with value of -0.0375 was highest in Year Dec-19 in last Five Years. |
| Debt to EBITDA Ratio of HRTX trending down for at least three Years. |
| Latest Debt to EBITDA Ratio with value of -1.51 is lower than Average Debt to EBITDA of -0.631 in last five years. |
Other Debt to EBITDA Related Info of HRTX that may interest you.
Heron Therapeuti Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| HRTX | 3.2 | 3.22 | 0.621 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| Poor Stability Stock | |
FY - Historical Debt to EBITDA of Heron Therapeuti
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| Debt to EBITDA | -1.51 | -0.857 | -0.699 | -0.0452 | -0.0375 | -0.0262 | -0.149 |
| Change | -76.82 % | -22.49 % | -1448.61 % | -20.37 % | -43.26 % | 82.47 % | 52.18 % |
FY Chart of Debt to EBITDA of Heron Therapeuti
Note : All Data Generated at the End of Trading Hours (EOD Data)